Candida rapid test could reduce mortality rates, study says

04/26/2013 | Medscape (free registration)

The T2Candida rapid blood test created by T2 Biosystems may significantly reduce mortality rates for patients diagnosed with Candida infection, which is the fourth-highest cause of hospital-acquired infections, researchers reported in Science Translational Medicine. Study investigator Dr. Eleftherios Mylonakis of Brown University said time to diagnosis is an important factor in Candida-related mortality and each hour of delay increases the risk.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI